Multicenter prospective trial of transbronchial cryobiopsy to evaluate its safety and utility
Not Applicable
- Conditions
- Diffuse interstitial lung disease (interstitial pneumonia, idiopathic pulmonary fibrosis, chronic hypersensitivity pneumonitis, sarcoidosis), malignant tumor (lung cancer, mesothelioma, metastatic lung carcinoma), respiratory infectious disease (tuberculosis, nontuberculosis mycobacterial infection, pulmonary aspergillosis), other diseases
- Registration Number
- JPRN-UMIN000033284
- Lead Sponsor
- Japanese Red Cross Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients are excluded if they have past history of severe allergy to sedative drugs (lidocaine, midazolam, pethidine and so on) 2) Patients are excluded if they are suspected to have tendency of bleeding from cryobiopsy lesion because of aneurysm of bronchoartery and lung metastasis of renal cell carcinoma and so on. 3) Patients are excluded if they can't stop anticoagulation therapy. 4) Patients are excluded if they have uncontrolled comlication such as unstable angina, acute myocardial infarction, heart failure and severe bronchial asthma attack. 5) Patients are excluded if they are pregnant. 6) Patients are excluded if their doctor decide not to include.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Provability of moderate to severe adverse events
- Secondary Outcome Measures
Name Time Method